Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared a post on LinkedIn:
“What a fantastic way to kick off ASCO2026!
I had the opportunity to present our work examining authorship patterns and trends in Phase III solid tumor clinical trials presented at the ASCO Annual Meeting over the past decade (2015–2025). It was an honor to share these findings with the oncology community and contribute to an important conversation about representation and leadership in cancer research.
A huge thank you to the American Society of Clinical Oncology (ASCO) for selecting our work for presentation.
This project would not have been possible without the outstanding efforts of Azza Sarfraz, Shree Rath, and Sara Abraham. Their dedication, attention to detail, and countless hours of work were instrumental in bringing this study to life.
And we’re just getting started.
Our GI Cancer team at Miami Cancer Institute has several exciting poster presentations and research updates coming over the next few days.
Stay tuned for more highlights from Chicago!”
Other articles featuring Sarbajit Mukherjee on OncoDaily.